Author : The Fly

Goldman Sachs downgraded Ginkgo Bioworks to Sell from Neutral with a price target of $1.25, down from $3, which represents 26% downside from current levels....

Check out this evening’s top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSMongoDB… To see the rest of the story go...

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1… To see the rest of the...

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1… To see the rest of the...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Rick Maturo, Director of Insights and Analytics at BDSA, a Colorado-based cannabis...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Revance Therapeutics… To see the...

Shares of AbbVie (ABBV) are down $5.44, or 4%, to $132.52 in early trading after Coherus BioSciences (CHRS) announced that the company plans to launch...

Check out this morning’s top movers from around Wall Street, compiled by The Fly. HIGHER – NRG… To see the rest of the story go...

Barclays analyst Gena Wang upgraded Bluebird Bio to Overweight from Equal Weight with a price target of $8, up from $7. After speaking to multiple...

DA Davidson analyst Gil Luria downgraded C3.ai to Neutral from Buy with an unchanged price target of $30. The company reported a slight beat to...